It is estimated that 50% of men will face a certain kind of problem with their prostate during their life, with benign prostate enlargement being the commonest one.
With advancing age, the glands that are found in the periurethral region of prostate are enlarged and surround urethra like a ring. The pathology of enlarged prostate is called benign hypertrophy of prostate.
Prostaplus Formula, due to its ingredients, inhibits 5-a-reductase, thus decreasing the synthesis of 5-a dihydrotestosterone. This results in the relaxation of muscular wall and the normalization of the function of bladder.
It also decreases prostate mass and gradually restores to a large extent, the function of urethra.
Thus, the difficulty in urination, the urgent need to urinate, or the problems of frequent urination and nocturia are reduced or disappear.
Dosage: Take 1 tablet a day after meal.
|
ΣΥΝΘΕΣΗ ΣΕ ΘΡΕΠΤΙΚΑ ΣΥΣΤΑΤΙΚΑ
|
ΑΝΑ ΗΜΕΡΗΣΙΑ ΔΟΣΗ
(1 δισκίο)
|
Σ.Η.Δ.
%
|
|
Serenoa Repens
(Saw Palmetto)
ξ.ε. 40% σε λιπαρά οξέα
|
200 mg |
|
|
Cucurbita Pepo
(Σπόροι Κολοκύθας)
ξ.ε. E/D : 1/4
|
200 mg |
|
|
Φυτοστερόλες
εκχύλισμα απo φλοιό πεύκου
|
100 mg |
|
|
Melissa Officinalis
ξ.ε. 2% σε ροσμαρινικό οξύ
|
100 mg |
|
|
Ψευδάργυρος
|
41 mg |
410% |
|
Ασκορβικό Οξύ
(Βιταμίνη C)
|
30 mg |
37,5% |
|
Οξική Τοκοφερόλη
(Βιταμίνη Ε)
|
67 mg |
558,3% |
|
Παλμιτική Ρετινόλη
(Βιταμίνη Α)
|
2 mg |
250%
|
Άλλα Συστατικά: μαλτοδεξτρίνη, διβασικό φωσφορικό ασβέστιο, άμυλο αραβοσίτου, στεατικό μαγνήσιο, πυρίτιο
WARNINGS: • This product is not intended for prevention, treatment or cure of the human disease. • Consult your doctor if you are pregnant, breastfeeding, or if you are under pharmaceutical treatment or face health problems.
Notification number of the European Medicines Agency (EMEA): 28339 / 8-4-2013 .
The notification number in the European Medicines Agency (EMEA) does not serve as a distribution permit from the European Medicines Agency (EMEA).
Barcode: 5200403400161
